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Correct development of the vertebrate body plan requires the early deﬁnition of two asymmetric, per-
pendicular axes. The ﬁrst axis is established during oocyte maturation, and the second is established by
symmetry breaking shortly after fertilization. The physical processes generating the second asymmetric,
or dorsal–ventral, axis are well understood, but the speciﬁc molecular determinants, presumed to be
maternal gene products, are poorly characterized. Whilst enrichment of maternal mRNAs at the animal
and vegetal poles in both the oocyte and the early embryo has been studied, little is known about the
distribution of maternal mRNAs along either the dorsal–ventral or left–right axes during the early
cleavage stages. Here we report an unbiased analysis of the distribution of maternal mRNA on all axes of
the Xenopus tropicalis 8-cell stage embryo, based on sequencing of single blastomeres whose positions
within the embryo are known. Analysis of pooled data from complete sets of blastomeres from four
embryos has identiﬁed 908 mRNAs enriched in either the animal or vegetal blastomeres, of which 793
are not previously reported as enriched. In contrast, we ﬁnd no evidence for asymmetric distribution
along either the dorsal–ventral or left–right axes. We conﬁrm that animal pole enrichment is on average
distinctly lower than vegetal pole enrichment, and that considerable variation is found between reported
enrichment levels in different studies. We use publicly available data to show that there is a signiﬁcant
association between genes with human disease annotation and enrichment at the animal pole. Muta-
tions in the human ortholog of the most animally enriched novel gene, Slc35d1, are causative for
Schneckenbecken dysplasia, and we show that a similar phenotype is produced by depletion of the or-
thologous protein in Xenopus embryos.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The ﬁrst steps of vertebrate development are guided by ma-
ternal mRNAs and proteins deposited during oogenesis. A subset of
these maternal factors is likely to control asymmetry for correct
axial development, and polymorphisms or deﬁciencies in these
may lead to defects in body patterning. An understanding of which
of these genes are asymmetrically expressed in the oocyte and
early embryo, and also implicated in human disease, may help to
direct research more effectively into the genetic causes of disease.
Xenopus is an ideal model system both for the discovery of
asymmetric and early acting genes, and the investigation of their
role in development.
Bilaterian animals require the early deﬁnition of twor Inc. This is an open access article
lchrist).asymmetric, perpendicular axes for correct development. The
process of axial differentiation in the embryo is controlled by two
main mechanisms: the action of maternal determinants trans-
mitted to speciﬁc blastomeres, and cellular interactions mediated
by various signaling molecules (Koga et al., 2012). Understanding
the speciﬁc molecular determinants of these processes remains an
important question in developmental biology. In many organisms,
these early events are accomplished by the localization or se-
questration of maternally synthesized proteins and mRNA (Da-
nilchik et al., 2006). Mechanisms vary in non-vertebrate species
(Gonczy and Rose, 2005; Kugler and Lasko, 2009; Steinhauer and
Kalderon, 2006), but in vertebrates, the animal–vegetal axis is set
up during oocyte maturation, and the dorsal–ventral axis is es-
tablished at or shortly after fertilization (Croce and McClay, 2006).
In Xenopus, the oocyte develops with radial symmetry around
the animal–vegetal axis between the darkly pigmented animal
pole and the lightly pigmented vegetal pole (Kageura, 1997). Fer-
tilization can only take place in the animal hemisphere, which
ensures that axial symmetry is broken in a stereotypical manner.under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Cortical rotation and the segregation of maternal gene products in the cleavage stage embryo. A. Orientation of early cell divisions. The ﬁrst cleavage plane is
determined by the sperm entry point (SEP) and the animal–vegetal (A–V) axis. The second cleavage is orthogonal to the ﬁrst but still contains the A–V axis; dorsal
blastomeres are deﬁned in the hemisphere opposite the SEP. The third cleavage is slightly above the equator. B. Displacement of maternal gene products. The egg contains
vegetally localized maternal gene products. A microtubule network is set up at fertilization and the outer layer, or cortex, of the single cell embryo rotates to displace the
vegetal cortical region away the SEP. Maternal gene products are displaced by movement with the cortex or by vesicle trafﬁcking into the presumptive dorsal hemisphere,
and are further segregated by subsequent cell divisions.
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content of the embryo, and the position of the sperm entry point
deﬁnes the orientation of the other axes with reference to the
animal–vegetal axis (Fig. 1A). Partway through the ﬁrst cell cycle,
the outer cortex of the embryo is rotated 30–40° degrees relative
to the core cytoplasm; the vegetal polar region moving away from
the sperm entry point (Gerhart et al., 1989). This cortical rotation,
either directly or indirectly, transports molecules from the poles of
the animal–vegetal axis to more equatorial regions (Houston,
2012) (Fig. 1B), which locates the dorsal end of the dorsal–ventral
axis in the opposite hemisphere to the sperm entry point (Da-
nilchik et al., 2006).
The cleavage plane of the ﬁrst cell division is deﬁned by the
plane of cortical rotation. The second cleavage plane, orthogonal to
the ﬁrst but still containing the animal–vegetal axis, segregates the
more dorsally distributed molecules from the more ventral ones.
The third cleavage plane, slightly above the equator towards the
animal pole, further compartmentalizes the segregated molecules
(Denegre et al., 1998) (Fig. 1B). On the dorsal side, this segregation
forms the basis for the Nieuwkoop center in the region of the
vegetal–dorsal blastomeres, and later the Spemann organizer (De
Robertis and Kuroda, 2004; Houston, 2012). In this scheme, the
ﬁrst cleavage determines the left and right halves of the animal,
and while these exhibit superﬁcial mirror symmetry, substantial
left–right internal asymmetry develops over time. Although this
has been investigated for some years, the molecular origins and
timing of the development of left–right asymmetry are not well
understood (reviewed in Blum et al., 2014; Coutelis et al., 2014).
Blastomere isolation and removal experiments have beencarried out with Xenopus embryos. These have shown that sepa-
rated halves of 2-cell stage embryos, and 8-cell stage embryos
containing some combination of ventral and dorsal blastomeres,
can still reach tailbud stage, whilst purely ventral halves give rise
to cell masses lacking head or axial structure (Kageura and Ya-
mana, 1983, 1984). Furthermore, the ability of transplants from
oocytes or early embryos to induce the formation of a secondary
axis in later stage embryos is evidence that some cytoplasmic
dorsal determinants are localized early in speciﬁc regions of the
embryos (Fujisue et al., 1993; Gallagher et al., 1991; Hainski and
Moody, 1992; Kageura and Yamana, 1986).
The nature and identities of these dorsal determinants are not
currently well deﬁned. Previous experiments have shown that
these putative cytoplasmic factors may be mRNA or proteins (Klein
and King, 1988; Miyata et al., 1987; Shiokawa et al., 1984). Further,
it has been argued that cytoplasmic polyadenylation may be the
mechanism for the change in dorsal inducing activity of total
RNA isolated from the dorsal lineage between the 8- and 16-cell
stages (Pandur et al., 2002). Differential polyadenylation along
the dorsal–ventral axis has been proposed to account for an
observed dorsal enrichment of Wnt11 protein (Schroeder et al.,
1999), and observed vesicle trafﬁcking has been proposed to
account for dorsal enrichment of Disheveled protein (Miller et al.,
1999).
The process of mRNA segregation in the maturing oocyte has
been well studied (King et al., 2005; Kloc et al., 2001, 2002; Mel-
ton, 1987), and numbers of mRNAs with an asymmetric distribu-
tion on the animal–vegetal axis are published (Cuykendall and
Houston, 2010; Houston, 2013; King et al., 2005).
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bryo has recently been investigated through transcriptional pro-
ﬁling of early cleavage stage embryos dissected in sections along
the animal–vegetal axis (Grant et al., 2014). A qPCR study on 41
selected genes, analyzed individual blastomeres (identiﬁed as
animal or vegetal) from 8-, 16- and 32-cell Xenopus laevis embryos
(Flachsova et al., 2013) and inferred a lack of dorsal–ventral or
left–right asymmetry from the failure of a principle components
analysis to identify subgroups beyond animal and vegetal. There
has, however, to the best of our knowledge, been no systematic,
large-scale study of mRNA distribution over multiple axes in the
blastula stage embryo. To comprehensively address the question of
asymmetry of maternal mRNAs in the cleavage stage embryo, we
have carefully disassembled 8-cell stage Xenopus tropicalis em-
bryos, recording the position of each blastomere within the em-
bryo, and performed whole transcriptome sequencing on the in-
dividual blastomeres.2. Materials and methods
2.1. In vitro fertilization and blastomeres collection
Adult X. tropicalis females were induced to ovulate and eggs
were fertilized, dejellied and cultured as previously described
(Khokha et al., 2002). At the two-cell stage, embryos, in which the
ﬁrst cleavage furrow bisects equally the pigmentation on the an-
imal pole, were selected as described (Grant et al., 2013). In this
way the lighter area can be used as a marker of the future dorsal
side (Klein, 1987; Masho, 1990). The selected embryos were
transferred to cell dissociation buffer enzyme-free, pbs (Gibco, Life
technologies), until the collection of the blastomeres at the 8-cell
stage. At this stage, the selected embryos were manually devi-
tellinated in dishes coated with 1% type V agarose. The blas-
tomeres were separated and collected from embryos where the
blastomeres were still linked by thin cytoplasmic bridges after
devitellination, enabling us to record the positions of blastomeres
within the embryo. Blastomeres were separated by creating a
gentle ﬂux of solution with the forceps against the cytoplasmic
bridges still present. Full sets of undamaged blastomeres were
collected in triReagent buffer (Sigma-Aldrich), immediately frozen
in liquid nitrogen and stored at 80 °C.
2.2. Veriﬁcation of dorsal–ventral axis orientation
Two-cell stage embryos were selected as described above, and
the presumptive dorsal hemisphere was noted at the four cell
stage. Dorsal and ventral blastomeres were injected with 1 nl of
Alexa 488-conjugated dextran or Alexa 680-conjugated dextran
(Thermo Fisher Scientiﬁc Inc.) respectively, and embryos were al-
lowed to grow to tailbud or tadpole stage before being examined
under ﬂuorescence light microscopy to check orientation with
respect to the original prediction of axis orientation.
2.3. RNA extraction and library preparation
RNA extraction from individual blastomeres was performed
using RNeasy Micro Kit (Qiagen) with some modiﬁcations. The
homogenization step was performed in triReagent buffer rather
than RLT buffer and chloroform was added in a ratio of 1:5 for
isolation of RNA. After centrifugation at 13,000 rpm for 30 min, the
colorless upper aqueous phase was transferred into a new RNase
free tube and manufacturer's instructions were followed. Samples
were dissolved in 15 ml of nuclease-free water. RNA concentrations
were measured with a Qubit 2.0 Fluorometer (Invitrogen), and
RNA integrity was assessed using the Agilent 2100 bioanalyzer(Agilent Technologies, Santa Clara, CA). Only samples character-
ized by an RNA integrity number48.0 were considered for library
construction. For 4 embryos (7, 17, 24 and 30), rRNA-depleted RNA-
seq libraries were prepared using the Ovation RNA-Seq System V2
(NuGEN Technologies Inc., San Carlos, CA). The libraries for Em-
bryo 1 were prepared differently: cDNA was synthetized directly
from the lysate cells using SMARTers Ultra Low RNA Kit (Clone-
tech Laboratories, Inc., CA). All library protocols were combined
with TruSeq DNA Sample Prep Kit v2 (Illumina, Inc.) and se-
quenced on the Illumina Hi-Seq 2500 platform to 60 bp, paired
end.
2.4. Sequence data analysis
Paired end reads were aligned to a set of transcript sequences
comprising the X. tropicalis v7.2 transcriptome and known off-
genome sequences derived from EST assemblies, as described
elsewhere (Collart et al., 2014). Alignment was performed using
bowtie2 v2.1.0 (Langmead and Salzberg, 2012) with parameters
“-k 200 -X 800 -t–rdg 6,5 –rfg 6,5 –score-min L,-.6,-.4–no-dis-
cordant –no-mixed”. Read pairs aligning uniquely with up to two
mismatches per read were counted. We calculated the library size
for each sample as total counted reads, excluding counts to ribo-
somal and other non-gene model sequences. To report read counts
we normalized by the library size to a standardized library of 25
million reads. We perform differential expression tests on raw
counts using the library size as a covariate. Genes with at least 10
normalized read counts in at least four blastomeres of any one
embryo were considered for differential expression analysis.
To establish the set of genes differentially expressed over any of
the animal–vegetal, dorsal–ventral or left–right axes, we combine
negative binomial regression with a likelihood ratio test. We per-
form identical tests for single and pooled embryos:
Let s j be the library size for sample j, and let rij be the raw count
of gene i in sample j. We assume that rij is negative binomially
distributed (Cameron and Trivedi, 1998) with mean ijμ and variance
ij i ij
2μ α μ+ , with iα the dispersion parameter for gene i. We consider
the null hypothesis that a gene is equally expressed in all blas-
tomeres: slog logij j i null,μ β= + , and an alternative hypothesis for
each axis that the gene is differentially expressed over axis a:
s a alog logij j j i a j i a, ,μ β β= + + ¯ ¯ , where a j and a j¯ are indicator
variables determining which side of the axis a the blastomere lies,
and the β parameters are log mean expression levels. For each gene,
we compute maximum likelihood estimates of the iα and i,β *
parameters under the null and alternative hypotheses. We perform
a likelihood ratio test: if Nℓ and Aℓ are the log-likelihoods of the null
and alternative models respectively then the test statistic
2 N A( )− ℓ − ℓ is assumed to be 12χ distributed under the null hy-
pothesis. We control the false discovery rate (FDR) using the Ben-
jamini–Hochberg method (Benjamini and Hochberg, 1995), and
determine the genes differentially expressed with an FDRo0.05.
We also consider a different form for the alternative in which
we simultaneously test for differential segregation over the
combinations of two axes or all three axes:
s a alog logij j q q j i a q j ia, , ,q qμ β β= + ∑ + ¯ ¯ , with aq indicating the re-
levant axes.
2.5. Annotating genes from Affymetrix microarray probe-set IDs
To improve the identiﬁcation of genes associated with the X.
laevis Affymetrix probe-set IDs, and in particular to link Affymetrix
IDs to our X. tropicalis reference transcript set, we combined BLAST
search data with paired-end information linking assembled EST
clusters. We used the following sets of sequences: Affymetrix
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cDNA sequences for accession numbers associated with Affymetrix
probes sets; assembled EST consensus sequences from builds Xt7
(X. tropicalis) and Xl4 (X. laevis) at http://genomics.nimr.mrc.ac.uk/
apps/ESTs/ (Gilchrist et al., 2004); and our transcript reference set,
which is reported previously (Collart et al., 2014). Affymetrix se-
quence ﬁles were BLASTed against all other ﬁles, the assembled
EST cluster consensus sequences were BLASTed against the tran-
script reference sequences, with an e-value limit of 1020, and best
hits per query sequence with a percent identity of at least 85%
were retained. Alternative routes through the data for each Affy-
metrix ID to transcript reference IDs were computed: (i) from
Affymetrix ID direct to transcript reference IDs, (ii) indirectly via
either set of EST cluster consensus sequences, and (iii) indirectly
via two EST clusters linked by paired end information. Identiﬁca-
tions were accepted where a clear majority of computed links
arrived at the same target; identiﬁcation was noted as ambiguous
where there was no clear best target; Affymetrix IDs were anno-
tated as unidentiﬁed if there were no links to reference transcript
sequences. Paired Affymetrix and reference transcript identiﬁers
are available in Supplementary ﬁle 1.
2.6. Finding orthologous human disease genes
To identify X. tropicalis orthologs of human disease genes we
ﬁrst downloaded human disease gene data from http://www.cbs.
dtu.dk/suppl/dgf/disease_complexes/networks/complexes.zip
(Lage et al., 2008). Diseases associated with human protein com-
plexes were transferred to all the genes within each complex.
Orthology relationships between human and X. tropicalis genes
were established via Ensembl and NCBI Entrez gene IDs and
matching to records on Xenbase gene pages (James-Zorn et al.,Fig. 2. A. Disassembling and sequencing the 8-cell stage embryo. Photograph of the inta
blastomeres. Sequencing of single blastomeres from a single embryo, showing layout of d
conﬁrm correct identiﬁcation of dorsal–ventral axis at the 4-cell, and by extension at th
blastomeres.2013). Human disease annotation was also taken directly from
Xenbase gene records (James-Zorn et al., 2013).
2.7. Morpholino knockdown analysis of Slc35d1
An antisense morpholino oligonucleotide, sequence 5′-
ACGTCTACCGACTTCCGCCATG-3′, was designed to target the 5′
untranslated region of the X. tropicalis gene solute carrier family
35, member D1 (Slc35d1) and block translation. A standard control
morpholino was also used to check the toxicity of the concentra-
tions used. All morpholinos were supplied by GeneTools (Philo-
math, OR). Doses of 10, 20, 30 and 40 ng of Slc35d1-MO or control-
MO were injected into the single-celled zygotes with ﬂuorescein-
labeled dextran. After injection, embryos were raised to stage 33
and ﬁxed in MEMFA solution. Embryos were stained for cartilage
with Alcian Blue using standard procedures (Klymkowsky and
Hanken, 1991).
Slc35d1-HA tagged mRNA was in vitro synthetized and injected
in one-cell stage embryos to check morpholino effectiveness
(Fig. 5A). The pCMV-slc35d1-HA was linearized with ApaI and
transcribed with the mMessage mMachine SP6 kit (Ambion). A
total of 200 pg of mRNA was injected into the one cell embryos
both alone and in conjunction with the Slc35d1-MO. Embryos
were collected 5 h after injection (stage 8/9) for protein extraction
and western blot analysis.
Collected embryos were homogenized in lysis buffer (1 M Tris
pH7.5, 5 M NaCl, 0.5 M EGTA, 10% Igepal CA-630, and 0,25% So-
dium deoxycholate) containing protease inhibitor mixture (Roche)
and centrifuged at top speed at 4 °C. Cell lysates were incubated
with polyclonal ChIP Grade anti-HA tag antibody (Abcam).
Immunocomplexes were precipitated using Dynabeads protein
A (Invitrogen) and separated by SDS-PAGE (12%). Afterct 8-cell embryo, and during microsurgical disassembly; note lighter dorsal/animal
isplayed data for known vegetally enriched gene, VegT. B. Dye tracing experiment to
e 8-cell, stage. The dorsal/animal quadrant is identiﬁed by more lightly pigmented
E. De Domenico et al. / Developmental Biology 408 (2015) 252–268256electrophoresis, the proteins were transferred to a PVDF mem-
brane 0.45 mm (BioRad). After blocking the membrane in Odissey
blocking buffer (LI-COR Bioscience, Ltd.-UK) in TBS, the blot was
incubated overnight at 4 °C with the antibody. The blot was then
washed and incubated with IRDye 800 CW goat-anti-mouse IgG
(LI-COR Bioscience Ltd., UK) and imaged using the LiCOR Odyssey
system.3. Results and discussion
3.1. Asymmetrically distributed mRNAs
To investigate the distribution of maternal mRNAs along the
three principle axes of the embryo, we carefully disassembled
8-cell stage X. tropicalis embryos showing stereotypical orientation
of the ﬁrst cleavage plane (Grant et al., 2013), noting the axial
location of each blastomere (vegetal–dorsal–left, etc.) (Fig. 2A). In
total we analyzed ﬁve such embryos, each from a different clutch,
constructing RNA-seq libraries for complete sets of individual
blastomeres from each embryo. For four of the embryos we made
ribosomal RNA-depleted libraries using the NuGEN Ovation v2 kit
to detect both unadenylated and polyadenylated mRNAs (total
mRNA), and for the ﬁfth embryo we used the Clonetech Labora-
tories low RNA SMARTer kit to detect polyadenylated mRNA
(polyAþ mRNA). RNA-seq data sets were labeled for embryo and
blastomere position, mapped to the X. tropicalis transcriptome and
normalized. The normalized gene counts for the blastomeres can
be found in Supplementary ﬁle 2. See Section 2 for more details.
To determine whether the dorsal pole of the dorsal–ventral
axis was correctly predicted at the 8-cell stage we performed
ﬂuorescent dye lineage tracing on 20 embryos from different
clutches with injection at the 4-cell stage (Fig. 2B and Section 2).
There were no inconsistencies: daughter cells from the predicted
dorsal blastomeres from the 4-cell stage made up the head,
anterior trunk and spinal cord in all cases (Fig. 2B).
We detected mRNA for 12,951 genes at a sufﬁcient level to test
for asymmetric distribution (Methods). We evaluated asymmetry
in two ways: in the individual embryos and in pooled data from all
embryos sequenced for total RNA (Ovation kits). The single em-
bryo data enabled us to assess the variability of mRNA asymmetry
between embryos, and allowed us to explore the possibility that
we had misidentiﬁed the dorsal end of the dorsal–ventral axis in
some embryos.
We used the same method for detecting asymmetry in both the
single and pooled embryo data. In pooled tests we treated RNA-
seq counts from the equivalently positioned blastomeres in dif-
ferent embryos as biological replicates. For each gene we per-
formed likelihood ratio tests, comparing two hypotheses for each
axis: ﬁrst that the distribution of mRNA was identical in all blas-
tomeres, second that the distribution of mRNAs was characterized
by different means at either end of the axis. Resulting p-values
were controlled with Benjamini–Hochberg FDR (Benjamini and
Hochberg, 1995). See Section 2 for details. The pooled data pro-
vided greater statistical power to detect asymmetry for a given
gene.
We ﬁrst present data from the pooled analysis of blastomeres
sequenced for total mRNA. We found 908 genes differentially ex-
pressed between animal and vegetal blastomeres with an
FDRo0.05. We did not ﬁnd any genes differentially expressed
along either the dorsal–ventral or left–right axes. In addition, we
tested for and found no genes differentially expressed over any
two axes taken together. Of the genes differentially expressed over
the animal–vegetal axis, we found 448 with increased expression
in the vegetal hemisphere with a mean fold-change of 4.2 (ranging
from 1.1 to 134.1), and 460 with increased expression in the animalhemisphere with a mean fold-change of 1.5 (ranging from 1.1 to
3.8). Examples of measured expression levels in the individual
blastomeres for a range of genes are shown, for both vegetal pole
enrichment (Fig. 3A) and animal pole enrichment (Fig. 3B). For
both groups of asymmetrically distributed mRNAs there was little
correlation between fold-change and expression level, whilst the
difference between the levels of enrichment at the two poles was
striking (Fig. 4A).
Analysis of the data at the single embryo level revealed that
genes shown to be asymmetrically distributed in the pooled ana-
lysis were not necessarily found to be signiﬁcantly differentially
expressed in each individual embryo. Consistency was greater at
both higher fold changes and baseline expression levels (Fig. 4A),
and we note that a small proportion of genes, detected as asym-
metrically distributed in the pooled data, were not detected as
such in any embryo on its own (Table 1). For a given gene the
measured fold change varied between embryos: summarizing over
all genes found asymmetric at the pooled level, we found that
93% of the fold changes found in individual embryos are within
2-fold of the fold change found in the pooled embryo tests. The
variation in fold-change, and the differences between the poles,
can be seen clearly in the distribution of fold-changes over all
asymmetric genes for each individual embryo (Fig. 4B). The range
of fold-change is always greater on the vegetal pole side, with
roughly the same number of genes compressed into a narrower
range on the animal side. We report the range of fold changes from
individual embryos in the tabulated lists of differentially expressed
genes (Table 2 and Supplementary ﬁle 3) as well as the number of
individual embryos in which they were found signiﬁcantly differ-
entially expressed. That we do not ﬁnd signiﬁcant differential ex-
pression in all embryos at the single embryo level (for genes found
asymmetric at the pooled level), is a consequence of the lack of
statistical power at this level, and not the lack of asymmetry. In
fact we ﬁnd that, in 95% of those cases where the signiﬁcance fell
below our (FDRo0.05) threshold, the fold-change still agreed in
direction with the fold-change from the pooled analysis.
We also used the single embryo data to verify that failure to
detect asymmetry along the dorsal–ventral or left–right axes was
not due to occasional mis-identiﬁcation of the orientation of the
dorsal–ventral axis in the embryos before disassembly. To do this,
we looked for genes with opposing asymmetry along either the
dorsal–ventral or left–right axes in data from different single
embryos. We found no examples of genes showing such behavior,
with FDRo0.05. We conclude that any dorsal–ventral or left–right
asymmetries in these embryos would be below the levels at which
we have detected asymmetry on the animal–vegetal axis
(i.e.o1.12-fold, see Table 1), and therefore not at levels where we
might expect the asymmetric distribution to have functional
consequences.
We report here the 74 genes whose maternal mRNAs were
consistently detected as differentially expressed over all ﬁve em-
bryos (Table 2): 65 enriched in the vegetal hemisphere with fold-
changes ranging from 134-fold to just under 2-fold, and 9 enriched
in the animal hemisphere with fold-changes ranging from 3.8-fold
to 1.7-fold. The full list of 908 differentially expressed genes is
provided in Supplementary ﬁle 3.
To investigate the relative asymmetry of polyadenylated tran-
scripts speciﬁcally, we compared the fold-change values from the
pooled embryo data (total mRNA) on the animal–vegetal axis with
those calculated for Embryo 1 (polyAþ mRNA). We found good
agreement between the fold changes (Fig. 4C), with a Spearman
correlation of 0.94. Furthermore, where there was more than one
embryo with a signiﬁcant fold-change in the single embryo total
mRNA data, over half of the polyAþ fold-changes for Embryo 1
(133/262) were inside the range of these values, and including all
genes where at least one embryo showed a signiﬁcant fold-
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within 2-fold either way of the average of the signiﬁcant fold-
changes in the total mRNA data. In general, the polyadenylation
status did not make a marked or systematic difference to the
asymmetry detected along the animal–vegetal axis.
3.2. Comparison with previously published genes
We next compared our data with asymmetrically distributed
maternal mRNAs reported in earlier studies. The majority of these
data were from two microarray studies in X. laevis: manually
dissected vegetal cortices from stage VI oocytes compared with
whole oocytes (Cuykendall and Houston, 2010), and 8-cell em-
bryos dissected in sections along the animal–vegetal axis com-
paring the animal blastomeres with a polar section of the vegetal
blastomeres (Grant et al., 2014). The ﬁrst of these provided a list of
120 genes enriched at least 6-fold in the vegetal cortex of the
oocyte; the second, a list of 285 genes enriched at least 3-fold (108
animal pole and 177 vegetal pole) in the dissected embryos. In
addition, 32 genes (14/18 animal/vegetal) from a qPCR study of
individual blastomeres (Flachsova et al., 2013), 38 genes (30/8
animal/vegetal) from a review of oocyte mRNA asymmetry (King
et al., 2005), and 12 genes from other publications (Betley et al.,
2002; Birsoy et al., 2005; Colozza and De Robertis, 2014; Freeman
et al., 2008; Horvay et al., 2006; Kloc and Chan, 2007; Machado
et al., 2005; Nakaya et al., 2004; Quick and Serrano, 2005;Fig. 3. Examples of single blastomere sequencing data for 8-cell stage embryos. Each pa
RNA libraries, blue are from total mRNA Ovation v2 libraries. Sufﬁxes: *novel in this stu
found in blastomeres data (Grant et al., 2014). Figures in brackets are fold-changes in thRutenberg et al., 2002; Tarbashevich et al., 2011, 2007).
For some of these X. laevis studies, the orthologous genes in our
X. tropicalis data were identiﬁed manually, by comparison of gene
symbols and known historical synonyms. However, the majority of
genes were reported with Affymetrix microarray probe-set IDs,
and these were often not well annotated. To identify themwe used
a computational approach to link the X. laevis Affymetrix IDs (v1
and v2) to the X. tropicalis gene identiﬁers used here (Section 2).
This enabled us to link 28,768 out of 32,317 Affymetrix IDs (v2) to
our reference sequence data, of which 2961 were ambiguous. We
note that around 20% of our X. tropicalis genes were not associated
with an X. laevis Affymetrix ID.
Collating genes between the different studies, we found that
there were 342 mRNAs previously reported in the literature as
exhibiting animal or vegetal enrichment in our reference tran-
script set. Surprisingly, we found only 115 of these in our list of 908
asymmetrically expressed genes from our pooled blastomere
analysis, even though we detected differential expression at much
smaller fold-changes than the thresholds used in the earlier stu-
dies. We report here the (74) mRNAs in our data for which we
found signiﬁcant asymmetry in all ﬁve embryos analyzed in-
dependently (Table 2). Even in this strongly asymmetric sub-set of
genes we found less than half (35) had been previously identiﬁed
in one or more earlier studies. The full list is provided in Supple-
mentary ﬁle 3.
We next looked at the correlation between the reported fold-nel contains sequence data for ﬁve embryos. Green is from polyAþ SMARTer low-
dy, °previously found in oocyte data (Cuykendall and Houston, 2010), bpreviously
is study. A. Vegetal pole enrichment. B. Animal pole enrichment.
Fig. 3. (continued)
E. De Domenico et al. / Developmental Biology 408 (2015) 252–268258changes of the enriched genes in our study and those in the earlier
microarray studies. Correlation with the animal/vegetal pole em-
bryo data (Grant et al., 2014) appeared to be moderate, whilst
there was little or no correlation with the vegetal cortex oocyte
data (Cuykendall and Houston, 2010) (Fig. 4D). In addition, genes
in our data with a slight difference in expression level along the
animal–vegetal axis but with an FDR40.05, were equally likely to
have been previously reported enriched at the opposite pole
(Fig. 4D). On average we reported lower fold changes than in
previous studies, notably at the animal pole (Fig. 4D), where, for
the set of genes in common, we report enrichment up to 3-fold
compared to the 3- to 10-fold reported in the earlier study (Grant
et al., 2014).
Inconsistent fold-changes between studies have been reported
previously (Grant et al., 2013) and we suggest that this might not
be unexpected, given both the difference in experimental designs,
and the known natural variability of maternal mRNAs between
clutches (Collart et al., 2014). The present study looks at differ-
ential expression between whole blastomeres and averages out
variation within the blastomeres; the earlier embryo study com-
pared the vegetal tips of the vegetal blastomeres with whole an-
imal blastomeres; and the earlier oocyte study compared the polar
vegetal cortex of the oocyte with whole oocytes. Without a more
detailed understanding of the global distribution of mRNAs within
the oocyte, egg and early blastomeres, it is difﬁcult to understand
the origin of the observed variation of fold changes between dif-
ferent studies.3.3. Novel segregated mRNAs
In order to identify novel, asymmetrically distributed mRNAs in
a manner consistent with previous studies we used the same
3-fold threshold as in the animal/vegetal pole embryo data (Grant
et al., 2014). With this threshold we found 128 enriched mRNAs, of
which 85 have not been previously described as enriched. All but
two were enriched at the vegetal pole. We note that these re-
present a mix of transcripts with and without Affymetrix IDs (50/
35 respectively), of which the former could have been detected in
the earlier studies, whilst the latter would not.
Six of the top eight vegetally enriched mRNAs, measured by
fold-change, were known (Fig. 4A), but the ﬁfth and sixth most
enriched were novel: an unidentiﬁed gene (Xetro.A00019), and
Srgap3 (slit-robo rho GTPase activating protein 3; Xetro.D02367)
(Fig. 4A lower). The expression levels of both are in the bottom 15%
of vegetally enriched genes (and the bottom 30% of all tested
genes). Srgap3 is a well conserved protein coding gene, although
not detected in the assembled X. tropicalis EST data (Gilchrist et al.,
2004). We ﬁnd its expression to be highly variable within each
embryo, but in this respect it is similar to Grip2 (Fig. 3A), which
has been shown to be important for the proper positioning of
primordial germ cells (Tarbashevich et al., 2007). In contrast,
A00019 is difﬁcult to characterize. It does not appear to be a pro-
tein coding gene; searching the NCBI nr protein database with
BLASTx returns no hits.
The most enriched gene in the animal hemisphere, measured
by fold-change, was novel: Slc35d1, solute carrier family 35 (UDP-
Fig. 4. Variation in enrichment within and between studies. A. Variation of fold-change with expression level at animal and vegetal poles in this study. Scatter plot of mean
expression level at the enriched pole against fold change measured between the poles for the 908 enriched genes in the pooled embryo analysis. Points are color coded
according to the numbers of individual embryos in which signiﬁcant asymmetric expression was detected in the single embryo analysis, see Key. Genes are clearly segregated
according to the consistency of detection at the single embryo level. The much greater fold-change for vegetal pole enrichment is clearly visible (note the log scale). Genes
enriched in our data and previously published are highlighted (black circles), and the most enriched novel mRNAs are indicated. B. Distribution of fold-changes at either pole
for individual embryos. C. Agreement of measured fold-changes between the pooled total mRNA data and the polyAþ mRNA data of Embryo 1: Spearman correlation¼0.94.
D. Correlation of gene enrichment between this study and earlier work. Scatter plots of enrichment fold-change on the animal–vegetal axis for genes in this study previously
reported as enriched in other studies. Left panel, blastomere data (Grant et al., 2014), right panel, oocyte data (Cuykendall and Houston, 2010). Full circles: genes enriched in
present study with FDRo0.05; open circles: genes not found enriched, with FDR40.05, fold-change in our data is simple ratio of vegetal/animal pole reads.
Table 1
Consistency of asymmetry measured at the single embryo level, compared to fold-
changes measured in the pooled analysis. The ﬁrst column is the number of in-
dividual embryos (maximum 5) for which a given gene is found to be asymme-
trically distributed at the single embryo level (FDRo0.05). Then for either pole, we
give the number of genes at each level of consistency, with the average and
minimum fold-change measured in the pooled data in each group.
Embryos Vegetal Animal
Genes Avg. fold Min. fold Genes Avg.
fold
Min.
fold
5 65 12.25 1.88 9 2.31 1.70
4 75 4.48 1.37 42 1.9 1.48
3 83 2.53 1.23 52 1.56 1.27
2 89 2.50 1.21 100 1.48 1.15
1 95 2.19 1.15 150 1.4 1.12
0 41 2.36 1.25 107 1.4 1.12
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member D1 (Fig. 4A upper). Slc35d1 is reported to be critical to
chondroitin sulfate synthesis in cartilage and skeletal develop-
ment in mouse and human (Hiraoka et al., 2007). There are many
more novel, asymmetrically expressed genes at lower levels of
enrichment, and the full list can be found in Supplementary ﬁle 3.
Of our list of 908 asymmetrically expressed genes, 793 have not
been previously reported; of the known ones, 88 were enriched at
the vegetal pole and 27 at the animal pole.
3.4. Human disease genes
As Xenopus is an excellent model system for studying early
development in vertebrates, we were interested to see which
genes with asymmetrically distributed maternal mRNAs were
orthologous to known human disease or disease associated
genes.
Table 2
List of mRNAs found asymmetrically distributed on the animal–vegetal axis in this study, where the pooled analysis asymmetry was conﬁrmed individually in all ﬁve embryos; novel mRNAs are indicated in column 3. Fold change is
measured between the mean expression level of pooled blastomere data at each end of the named axis over four embryos; the range of fold-changes found in the single embryos analysis is also given. The expression level is the
mean expression at the higher end of the axis in the pooled data. Fold changes, where known, and gene symbols reported in other studies are indicated in relevant columns. Disease genes were annotated via orthologs of human
disease associated genes from Omim (www.omim.org) and published work on protein complexes (Lage et al., 2008), and also taken directly from Xenbase (James-Zorn et al., 2013), see text. Previously published mRNAs are
referenced as follows, column headings: (Grant et al., 2014; Flachsova et al., 2013; Cuykendall and Houston, 2010; King et al., 2005). Other: (Betley et al., 2002; Birsoy et al., 2005; Colozza and De Robertis, 2014; Freeman et al., 2008;
Horvay et al., 2006; Kloc and Chan, 2007; Machado et al., 2005; Nakaya et al., 2004; Quick and Serrano, 2005; Rutenberg et al., 2002; Tarbashevich et al., 2011; Tarbashevich et al., 2007).
Gene Pole Status Fold Range Expression
level
Affy ID v1 Affy ID v2 Associated disease Grant Flachova Cuykendall King Other
Xetro.D02339|
grip2
Veg 134.11 (5) 49.21–
213.15
6842.8 Xl.14891.1.
S1_at
Xl2.52312.1.
S1_at
Cofﬁn–Lowry syndrome; diabetes mellitus,
noninsulin-dependent; leukemia, juvenile
myelomonocytic
10.57 (xgrip2) Tarb 07
Xetro.G00091|
nanos1
Veg 97.32 (5) 51.43–
151.47
546.6 Xl.1145.1.
S1_at
Xl2.1145.1.
A1_at
Spermatogenic failure 12 16.04 (xcat2) Betl 02
Xetro.E00365|
pat
Veg 94.4 (5) 34.54–
178.98
4588.5 Xl.38.1.S1_at Xl2.38.1.S1_at 6.93 (xpat) (xpat) Mach 05
Xetro.A00019| Veg novel 59.12 (5) 22.21–
186.66
128.9 – –
Xetro.G01160|
ddx25
Veg 37.06 (5) 26.65–
61.12
9146.2 Xl.670.1.
S1_at
Xl2.670.1.S1_at 24.16
(ddx25)
(ddx25) 9.24
(dead*south)
(DEADSouth)
Xetro.H00537|
wnt11b
Veg 25.52 (5) 12.83–
33.12
1858.3 Xl.1073.1.
S1_at
Xl2.44504.2.
S1_a_at
8.43 (wnt11) (Xwnt11)
Xetro.A00580|
trim36
Veg 17.74 (5) 12.09–
24.86
19264.8 Xl.6926.1.
S1_at
Xl2.6926.1.
S1_at
(trim36) 24.93
(MGC81170;
trim36)
Xetro.C00749|
pcsk6
Veg 17.4 (5) 9.23–
33.34
4505.4 – Xl2.48635.1.
S2_at
Birs 05
Xetro.F00403|
sulf1
Veg 15.94 (5) 10.59–
36.44
4357.1 Xl.20564.1.
A1_at
Xl2.20564.1.
S1_at
Free 08
Xetro.N00856|
vegt
Veg 13.52 (5) 11.28–
28.78
11644.3 Xl.1775.1.
S1_at
Xl2.1775.1.S1_at 4.61 (vegt-a) (vegt) 3.56 (vegt) (VegT)
Xetro.G00335|
bicc1
Veg 12.91 (5) 9.39–
26.43
11865.5 Xl.7094.1.
S1_a_at
Xl2.7094.1.
S1_a_at
17.12 () 14.27 (–) (xBic-C)
Xetro.A02015|
gdf1
Veg 12.36 (5) 7.58–
22.08
2258.7 Xl.25780.1.
S1_at
Xl2.25780.1.
S2_at
Right atrial isomerism; transposition of great
arteries, dextro-looped 3; conotruncal anomaly
face syndrome; tetralogy of fallot
34.73 (gdf1) (vg1) 3.77 (vg1) (Vg1)
Xetro.I00813|
mogat1
Veg novel 11.13 (5) 7.17–
16.71
2464.3 Xl.7867.1.
S1_at
Xl2.7867.1.
S1_at
Xetro.A01360|
mov10
Veg novel 10.28 (5) 7.66–
30.84
14163.7 – Xl2.52320.1.
S1_at
Xetro.E01314|
otx1
Veg 10.25 (5) 7.43–
27.25
19156 Xl.781.1.
S1_at
Xl2.781.1.S1_at Cutis laxa, autosomal recessive, type ia 19.84 (otx1) (otx1) 7.18 (otx1) (Xotx)
Xetro.K02810|
slc12a9
Veg novel 9.91 (5) 5.17–
30.20
617.3 – Xl2Affx.115.1.
S1_at
Xetro.F00192|
sybu
Veg 9.87 (5) 6.22–
15.34
6385.3 – Xl2.8441.1.S1_at Colo 14
Xetro.I01736|
thoc6
Veg novel 7.94 (5) 4.54–
12.64
3028.5 – Xl2.11109.1.
S1_at
Xetro.A01296|
slc25a22
Veg novel 7.76 (5) 6.34–
17.48
837.5 Xl.26141.1.
S1_at
Xl2.24565.1.
A1_at
Epileptic encephalopathy, early infantile, 3
Xetro.J00911|
spire1
Veg 7.74 (5) 5.48–
10.35
23589.6 – Xl2.7501.1.S1_at Smith–Magenis syndrome; deafness, autosomal
dominant 4a; glomerulosclerosis, focal seg-
mental, 1; deafness, autosomal dominant 48
13.43
(spire1)
Xetro.H00830| Veg novel 7.42 (5) 6.29–
8.53
14434.3 Xl.7236.2.
A1_at
Xl2.54089.1.
S1_at
Xetro.A00833|
unnamed
Veg novel 7.22 (5) 4.96–
9.62
879.5 – –
Xetro.C01112| Veg 7.16 (5) 5.35– 3707.9 Xl.25471.1. Xl2.29785.1. 3.60 (dnd1) 5.06 (dead*end) Horv 06
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dnd1 25.55 A1_at S2_at
Xetro.F01892|
ctdspl
Veg 7.09 (5) 3.73–
17.59
14334 Xl.18931.1.
A1_at
Xl2.18931.1.
S1_at
13.21
(ctdspl)
6.37 (nif)
Xetro.A01886|
rnf38
Veg 6.94 (5) 4.36–
19.21
17191.6 Xl.5623.1.
A1_at
Xl2.52368.1.
S1_at
13.11 () 10.05 (–)
Xetro.F00384|
rdh10
Veg 6.64 (5) 4.64–
13.62
13302 Xl.24399.1.
A1_at
Xl2.47730.1.
S1_at
6.98
(MGC80820)
Xetro.I00127|
cnppd1
Veg 6.16 (5) 4.67–
13.70
5967.5 Xl.7190.1.
A1_at
Xl2.7190.1.
S1_at
19.05
(cnppd1)
6.74
(MGC115028)
Xetro.G00368|
fgfr2
Veg 5.88 (5) 3.54–
13.85
931.7 Xl.1182.1.
S1_at
Xl2.21506.1.
A1_at
Bent bone dysplasia syndrome; ladd syndrome;
Antley–Bixler syndrome without genital
anomalies or disordered steroidogenesis; gastric
cancer, somatic; apert syndrome; scaphoce-
phaly, maxillary retrusion, and mental retarda-
tion; Jackson–Weiss syndrome
11.36 (fgfr2)
Xetro.C00709|
rhcg
Veg novel 5.8 (5) 3.72–
7.05
1381.4 – Xl2.31959.1.
S1_at
Xetro.B00467|
cnksr2
Veg novel 5.77 (5) 4.95–
6.68
5149 – Xl2.47631.1.
S1_at
Xetro.K05126|
sox7
Veg 5.71 (5) 3.25–
12.31
2974.8 Xl.1241.1.
S1_at
Xl2.1241.1.S1_at 4.86 (sox7)
Xetro.A02337|
ppp1r3b
Veg 5.33 (5) 4.37–
7.09
21289.8 Xl.7655.1.
S1_at
Xl2.7655.1.
S1_at
Muscle glycogenosis; diabetes mellitus, type 2,
susceptibility to; mcardle disease; phosphor-
ylase kinase deﬁciency of liver and muscle, au-
tosomal recessive; glycogen storage disease 0,
liver; ossiﬁcation of the posterior longitudinal
ligament of spine;
3.15
(ppp1r3b-a)
8.46
(MGC85023)
Xetro.B00074|
rragc
Veg novel 5.26 (5) 4.56–
8.78
7477.7 – Xl2.7005.1.
S1_at
Xetro.A02205|
acsbg2
Veg 5.06 (5) 4.18–
9.59
15304 Xl.5085.1.
A1_at
Xl2.5125.1.
S2_at
7.41
(acsbg2)
Xetro.I00550|
raph1
Veg novel 4.99 (5) 3.16–
10.12
3402.8 Xl.15448.2.
A1_at
Xl2.15448.1.
S1_at
Xetro.D02536| Veg novel 4.59 (5) 3.04–
13.56
906.3 – Xl2.29748.1.
A1_at
Robinow syndrome, autosomal dominant; exu-
dative vitreoretinopathy 2, x-linked; exudative
vitreoretinopathy 4; [bone mineral density
variability 1]; exudative vitreoretinopathy 1;
parkinson disease 6, early onset;
Xetro.D01936|
plk3
Veg novel 4.48 (5) 3.56–
5.49
27440.1 Xl.19981.1.
S1_at
Xl2.8085.1.
S1_at
Esophageal squamous cell carcinoma, somatic;
lung cancer, somatic; choroid plexus papilloma;
squamous cell carcinoma, head and neck, so-
matic; li-fraumeni syndrome;
Xetro.F01128|
velo1
Veg 4.33 (5) 3.84–
9.66
18561.9 Xl.491.1.S1_at Xl2.491.1.
S1_a_at
5.44 (velo1) (Xvelo)
Xetro.B00910|
cldn4
Veg novel 4.27 (5) 2.20–
7.08
9651.6 Xl.6291.1.
A1_at
Xl2.53796.2.
A1_at
Xetro.H00419| Veg novel 4.02 (5) 3.04–
7.02
1090.5 Xl.690.1.
S2_at
Xl2.690.1.S1_at
Xetro.A02978|
acsl1
Veg 3.87 (5) 2.30–
5.18
6049.8 Xl.15591.1.
S1_at
Xl2.7122.1.
S1_at
Myopathy due to cpt ii deﬁciency; cpt deﬁ-
ciency, hepatic, type ia; cpt deﬁciency, hepatic,
type ii; cpt ii deﬁciency, lethal neonatal; acyl-
coa dehydrogenase, medium chain, deﬁciency
of; nephronophthisis 3; peroxisomal acyl-coa
oxidase deﬁciency;
6.33 () 20.58 (facl2) (XFACS)
Xetro.B01314|
rnf41
Veg novel 3.85 (5) 2.34–
6.42
6800.8 Xl.3157.1.
A1_at
Xl2.3157.1.S1_at
Xetro.D01271|
pbx1
Veg novel 3.79 (5) 2.79–
4.73
2182.2 Xl.9563.1.
S1_at
Xl2.40234.1.
S1_at
Coloboma of optic nerve; ectopia pupillae; fo-
veal hypoplasia 1; keratitis; optic nerve hypo-
plasia; aniridia; coloboma, ocular; peters
anomaly;
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Table 2 (continued )
Gene Pole Status Fold Range Expression
level
Affy ID v1 Affy ID v2 Associated disease Grant Flachova Cuykendall King Other
Xetro.D00562|
pc.1
Veg 3.76 (5) 2.82–
5.75
2613.3 Xl.16639.1.
A1_at
Xl2.16639.1.
S2_at
Pyruvate carboxylase deﬁciency; glutaricacidur-
ia, type i; cardiomyopathy, familial hypertrophic
6; lacticacidemia due to pdx1 deﬁciency; cho-
lesteryl ester transfer protein deﬁciency; pyr-
uvate kinase deﬁciency; charcot-marie-tooth
disease, type 2d
7.97 (pc.1)
Xetro.G00513|
sufu
Veg novel 3.57 (5) 2.63–
7.52
3813.4 Xl.10858.1.
A1_at
Xl2.47662.1.
S1_at
Meningioma, familial, susceptibility to; basal
cell nevus syndrome; peroxisome biogenesis
disorder 1b (nald/ird); peroxisome biogenesis
disorder 3b; peroxisome biogenesis disorder 2b;
peroxisome biogenesis disorder 1a (zellweger);
medulloblastoma
Xetro.B01376|
lrp1
Veg 3.47 (5) 2.49–
8.30
11835.5 Xl.10926.1.
A1_at
Xl2.18251.1.
S1_at
Neutropenia, cyclic; corneal dystrophy, groe-
nouw type i; corneal dystrophy, lattice type i;
corneal dystrophy, avellino type; corneal dys-
trophy, Reis–Bucklers type; corneal dystrophy,
lattice type iiia; Bernard–Soulier syndrome, type
b
9.03 (lrp1) 7.45 (–)
Xetro.K00842| Veg 3.32 (5) 2.59–
6.49
11744.4 Xl.7672.1.
S1_at
Xl2.7672.1.
S1_at
7.36 () 6.26 (–)
Xetro.K02822|
znf484
Veg novel 3.17 (5) 2.28–
3.95
484.7 – –
Xetro.K01814| Veg novel 2.92 (5) 2.31–
3.36
1665.6 – –
Xetro.D02087| Veg 2.92 (5) 2.68–
3.81
14753.6 – Xl2.25589.1.
A1_at
3.43 (rpap3)
Xetro.B01421|
unnamed
Veg novel 2.78 (5) 2.05–
3.51
6624.5 Xl.5306.1.
S1_at
Xl2.55308.1.
A1_x_at
Xetro.H01623|
daam1
Veg 2.75 (5) 1.92–
5.33
8593.7 Xl.25142.1.
A1_at
Xl2.14901.1.
A1_at
Naka 04
Xetro.D00538|
fam65a
Veg 2.62 (5) 2.01–
3.25
12257 Xl.11436.1.
A1_at
Xl2.54196.1.
S1_at
8.43 (–)
Xetro.D01911|
c1orf190
Veg 2.52 (5) 2.04–
3.49
2837.4 Xl.18636.2.
A1_at
Xl2.18636.2.
A1_at
Cerebral dysgenesis, neuropathy, ichthyosis, and
palmoplantar keratoderma syndrome
5.33 () 10.10 (–)
Xetro.E00863|
dynlt1
Veg novel 2.5 (5) 1.89–
4.61
1843.3 Xl.25778.2.
A1_at
Xl2.25778.1.
S1_at
Xetro.K00790|
unnamed
Veg novel 2.45 (5) 2.09–
2.83
3740.6 – –
Xetro.D02050|
ralgps2
Veg 2.43 (5) 1.94–
3.46
8900.2 Xl.15398.1.
A1_at
Xl2.15398.1.
S1_at
10.21 () 6.69 (–)
Xetro.A00139|
gpbp1
Veg novel 2.4 (5) 2.14–
5.49
1751 Xl.10420.1.
A1_at
Xl2.10420.1.
S1_at
Xetro.A02066|
tbc1d1
Veg novel 2.4 (5) 1.92–
2.95
10331.8 – Xl2.51321.2.
A1_at
Renal cell carcinoma, papillary; craniofacial-
skeletal-dermatologic dysplasia; hyper-
eosinophilic syndrome, idiopathic, resistant to
imatinib; growth retardation with deafness and
mental retardation due to igf1 deﬁciency;
crouzon syndrome
Xetro.A00748|
slc15a4
Veg novel 2.28 (5) 1.83–3.12 5433 Xl.11559.2.
A1_at
Xl2.11559.1.
S1_at
Xetro.F01187|
trak1
Veg 2.2 (5) 1.78–
2.65
4548.3 Xl.3942.1.
A1_at
Xl2.14609.1.
A1_at
7.25 (trak1) 6.33 (–)
Xetro.C01467|
pdlim7
Veg novel 2.09 (5) 1.60–
3.61
3072.3 Xl.24906.1.
S1_at
Xl2.24906.1.
S1_at
Arthrogryposis multiplex congenita, distal, type
1; cap myopathy 2; cirrhosis, cryptogenic
Xetro.B00109| Veg novel 1.99 (5) 1.54– 2626.4 – –
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eif2c1 2.76
Xetro.D02103|
kifc3
Veg novel 1.93 (5) 1.65–
2.55
2547.1 – Xl2.47072.1.
S1_at
Xetro.E00664| Veg novel 1.88 (5) 1.70–
2.05
5609 Xl.7576.1.
A1_at
Xl2.7576.1.
S1_at
Xetro.D01799|
slc35d1
Anim novel 3.83 (5) 2.96–
5.35
1912.7 Xl.15597.1.
A1_at
Xl2.15597.1.
S1_at
Schneckenbecken dysplasia
Xetro.A01057|
smtn
Anim 2.83 (5) 2.43–
3.25
14249.3 Xl.7657.1.
S1_at
Xl2.30815.1.
S1_at
Prostate cancer, somatic; glioma susceptibility 1;
persistent mullerian duct syndrome, type ii;
parkinson disease, susceptibility to; exudative
vitreoretinopathy 1; brachydactyly, type a2;
parkinson disease 6, early onset; endometrial
cancer, familial
4.45 (smtn)
Xetro.C00309|
slc18a2
Anim novel 2.65 (5) 1.94–
3.09
5710.6 Xl.2817.1.
S1_at
Xl2.12817.1.
A1_at
Xetro.I00501|
nbeal1
Anim novel 2.38 (5) 1.79–
2.89
8503.6 – –
Xetro.B00228|
stk40
Anim novel 2.11 (5) 1.71–
2.34
7574.6 Xl.15814.3.
A1_at
Xl2.29416.1.
S1_at
Xetro.I01183|
nomo3
Anim novel 1.82 (5) 1.45–2.10 6120.2 Xl.9133.1.
A1_at
Xl2.56596.1.
S1_at
Xetro.E01463|
bub1
Anim novel 1.75 (5) 1.45–
2.06
9400.8 Xl.754.1.
S1_at
Xl2.754.1.
S2_a_at
Xetro.A01908|
ptpn9
Anim novel 1.74 (5) 1.43–1.95 3182.6 Xl.12128.1.
S1_at
Xl2.883.2.
S1_a_at
Xetro.H00897|
rbmx
Anim novel 1.7 (5) 1.22–2.12 2392.2 Xl.25221.1.
S1_at
Xl2.25221.2.
S1_a_at
Cornelia de lange syndrome 2; oculopharyngeal
muscular dystrophy; cerebral hemorrhage with
amyloidosis, hereditary, dutch type; griscelli
syndrome, type 1; elejalde disease; griscelli
syndrome, type 3; keratosis palmoplantaris
striata i, ad
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E. De Domenico et al. / Developmental Biology 408 (2015) 252–268264To explore the association with disease we linked 4173 X. tro-
picalis genes (about 20% of the estimated total number of genes)
through orthology data to human genes associated with disease in
a high conﬁdence protein interactome (Lage et al., 2008) covering
1048 human disease entries in OMIM (Methods). In addition we
downloaded a set of 2653 X. tropicalis genes orthologous to human
disease gene directly from the Xenopus community database,
Xenbase (James-Zorn et al., 2013). Together these yielded a set of
5428 human disease orthologs which we used to test for enrich-
ment of disease genes amongst the asymmetrically distributed
cohorts. The full list of genes and diseases can be found in Sup-
plementary ﬁle 4.
We ﬁrst tested to see whether genes with asymmetric ex-
pression were enriched for human disease orthologs. Out of the
12,951 genes tested for differential expression, we found 4068
with a human disease annotation. Of the 908 asymmetric genes,
312 had a human disease annotation, compared to the 285 genes
we would have expected by chance, suggesting a mild association
between asymmetry and disease (p¼0.049 Fisher Exact test). We
then looked to see if the direction of the enrichment was related to
the degree of association. Enriched at the vegetal pole, we found
135/448 genes with a disease annotation, slightly less than would
be expected by chance. In contrast, amongst the genes enriched atFig. 5. Exploration of morpholino knockdown of Slc35d1. A. In vitro validation of Slc35
phenotype of Slc35d1-MO injected embryos, with approximate dosage effect up to 30 n
concentrations (see Table 3). C. Comparison of uninjected and 30 ng Slc35d1-MO injected
Expression proﬁle of Slc35d1 shows signiﬁcant levels of polyAþ mRNA maintained intothe animal pole, we found 177/460 genes with a disease annota-
tion, 32 more than would be expected by chance (p¼0.001 Fisher
Exact test). We conclude that there is a signiﬁcant association
between genes with human disease annotation and enrichment at
the animal pole, and that the weak association between human
disease and asymmetric genes per se is due to those genes found
enriched at the animal pole. This was a somewhat counter-in-
tuitive result, as we expected the signiﬁcantly larger asymmetries
to be more associated with disease. Human disease associations
with genes that were consistently found asymmetrically expressed
are reported within Table 2, and the remainder can be found in
Supplementary ﬁle 3.
The most asymmetrically expressed novel gene in the animal
blastomeres, Slc35d1, is implicated in the human disease
Schneckenbecken dysplasia (Borochowitz et al., 1986), considered to
be associated with a dwarﬁsm phenotype (Lahmar-Boufaroua
et al., 2009). To explore the importance of this gene in X. tropicalis
during early development we injected a translation blocking
morpholino oligonucleotide at different concentrations (Section
2). Effectiveness of the Slc35d1-MO was determined separately by
injection of Slc35d1-HA mRNA. Control embryos were injected
with matched levels of standard control morpholino, and were
developmentally unaffected until at least the tadpole stage, whend1-MO blocking translation of HA tagged Slc35d1 protein. B. Body axis shortening
g injected MO, at stage 33. Penetrance of the phenotype was at least 94% over all
embryos under Alcian Blue staining suggests major loss of skeletal development. D.
gastrulation (Collart et al., 2014).
Table 3
Penetrance of phenotype in Slc35d1-MO injected embryos. Number of observed
short-axis phenotypes in each group of embryos injected with different levels of
the Slc35d1 Morpholino at the single cell stage. Observations made at Stage 32/33.
Slc35d1-MO concentra-
tion (ng/embryo)
Embryos
injected
Short-axis
phenotype
Penetrance
(%)
10 84 81 96
20 88 86 98
30 94 88 94
40 97 94 97
E. De Domenico et al. / Developmental Biology 408 (2015) 252–268 265observations ceased. Slc35d1-MO injected animals showed shorter
dorsal axis with poor development of dorsal tissues and head, and
by tadpole stage had died and degraded. Increasing concentrations
of injected morpholino caused progressive increase in the severity
of the morphant phenotype (Fig. 5B), and penetrance was high (at
least 94%) at all concentrations (Table 3). To highlight cartilage
tissue we stained embryos at tailbud stage with Alcian blue, as
described previously (Klymkowsky and Hanken, 1991), which
showed partial or complete loss of vertebrate cartilage primordia
(Fig. 5C). It is unclear what the role of animal pole enrichment is
for the function of this gene. We note that the expression level of
the gene is maintained well into gastrulation (Fig. 5D), although
whether the asymmetry is maintained during zygotic transcription
is not known. Our ﬁndings suggest that Xenopus embryos develop
a lethal form of skeletal dysplasia in a similar manner to Slc35d1-
deﬁcient mice (Hiraoka et al., 2007) and humans, highlighting the
power of the Xenopus model system for the study of prenatal
dysplasia, and potentially of other developmental disease
syndromes.
In addition, amongst the more consistently asymmetric genes
enriched at the animal pole (in at least 4/5 single embryo tests) we
ﬁnd four further novel genes with human disease associations and
greater than two-fold enrichment. In decreasing order of enrich-
ment they are: Mprip, 3.1-fold, implicated in ogna type epi-
dermolysis bullosa simplex, muscular dystrophy, and cryptogenic
cirrhosis; Fam82a2, 2.3-fold, implicated in Pelger–Huet anomaly,
greenberg skeletal dysplasia, familial hypercholanemia, and other
diseases; Acaca, 2.2-fold, implicated in acetyl-coa carboxylase de-
ﬁciency; and Dck.2, 2.1-fold, implicated in partial adenosine dea-
minase deﬁciency, mitochondrial myopathy and sideroblastic an-
emia 1, and other diseases.
Amongst the more consistently asymmetric genes enriched at
the vegetal pole (in at least 4/5 single embryo tests) we ﬁnd six
novel genes with human disease associations and greater than
four-fold enrichment. In decreasing order of enrichment they are:
Farp2, 16.2-fold, implicated in Ehlers–Danlos syndrome type viib,
type iii and iv osteogenesis imperfect, and other diseases;
Slc25a22, 7.8-fold, implicated in early infantile encephalopathy 3;
Pld2, 7.5-fold, implicated in diabetes mellitus type 2, generalized
congenital lipodystrophy type 1, lung cancer, and other diseases;
Mark4, 4.7-fold, implicated in Hermansky–Pudlak syndrome 1;
D02536, 4.6-fold, implicated in autosomal dominant robinow
syndrome, and amongst others, early onset parkinson disease 6;
and Plk3, 4.5-fold, implicated in esophageal squamous cell carci-
noma, lung cancer, and other diseases.
Although it is not clear how many of these disease associations
will ultimately be traceable to asymmetries in the early embryo,
these data underline the viability of X. tropicalis as a model for
human disease, especially where the development of the early
embryo is affected. The rapidly developing and accessible early
embryos enable the simple observation of the onset of the disease
phenotype, and would provide a large scale and cost effective
vehicle for screening potential therapeutic interventions.3.5. Insights into the behavior of candidate dorsalizing proteins
It has been proposed that differential polyadenylation, ob-
served along the dorsal–ventral axis, accounts for dorsal enrich-
ment of Wnt11 protein in the early X. laevis embryo. A seven-fold
difference in the level of polyadenylated Wnt11 mRNA was re-
ported between the dorsal and ventral halves of the embryo at the
32-/64-cell stage, against a uniform background of total mRNA for
this gene (Schroeder et al., 1999); also, a 60% spike in polyAþ
Wnt11 mRNA levels over the whole embryo between fertilization
and the 2-cell stage was noted. This X. laevis Wnt11 maps (using
the published primers) to X. tropicalis Wnt11b. Our analysis shows
that Wnt11b is strongly enriched (25.5 fold) at the vegetal pole,
and this is seen in both the polyAþ and total mRNA data (Fig. 6A).
Looking at the polyAþ expression levels in the individual blas-
tomeres for Embryo 1, we note that expression in the dorsal
blastomeres is slightly lower than in the ventral blastomeres, and
therefore more supportive of ventral than dorsal enrichment. It
appears unlikely that Wnt11b is signiﬁcantly enriched for poly-
adenylated mRNAs in the dorsal hemisphere at the 8-cell stage in
our data. Signiﬁcant changes in polyadenylation post-fertilization
have been observed for many genes (Collart et al., 2014), and
Wnt11b is progressively deadenylated in that data, measured over
the whole embryo, during the cleavage stages. There are two other
Wnt11's in the X. tropicalis genome: one is annotated asWnt11, the
other is un-annotated (H00536), but appears to be an inverted
local duplication of Wnt11b. This latter shows (weaker) vegetal
enrichment (2.2 fold), and neither shows any evidence of differ-
ential polyadenylation. If this mechanism is operational in X. tro-
picalis, these results would suggest that the differential poly-
adenylation would need to take place between the 8- and 32-cell
stages. We look forward to investigating this phenomenon more
deeply in future work.
In the case of Wnt11b, we see no evidence in our data for dif-
ferential polyadenylation along the dorsal–ventral axis by the
8-cell stage. Interestingly, when we extend this question to all
other genes, we ﬁnd no genes showing asymmetric distribution of
polyadenylated mRNA along the dorsal–ventral axis (all genes
have FDR40.76). We therefore ﬁnd no support in our data for
differential polyadenylation along the dorsal–ventral axis, acting
on a uniform distribution of underlying maternal mRNA. Neither
do we ﬁnd evidence (presented above) for asymmetric distribu-
tion of total mRNA along this axis, which could have allowed
different levels of polyAþ mRNA to accumulate in the two
hemispheres at a later stage.
Ventral to dorsal vesicle-based trafﬁcking of Disheveled protein
has been observed, after cortical rotation and before the ﬁrst
cleavage, and is noted to be microtubule dependent; and Dishev-
eled protein was found to be associated with vesicle-like orga-
nelles at the vegetal pole (Miller et al., 1999). There appear to be
three Disheveled genes in X. tropicalis: Dvl1, is expressed at very
low levels, and the read counts are below our threshold for testing,
whilst both Dvl2 and Dvl3 are much more highly expressed. In-
terestingly, their maternal mRNAs do not show any signiﬁcant
asymmetry (animal–vegetal or dorsal–ventral) in the blastomeres,
in either the total mRNA or the polyAþ mRNA data (Fig. 6B). These
data suggest that Disheveled protein could be produced from
mRNAs more widely distributed in the egg, or oocyte, than at the
vegetal pole, although we have no direct evidence for this. This
would however be consistent with the role of cortical rotation to
set up a dorsally directed microtubule network capable of trans-
locating dorsalizing agents from (potentially) any part of the em-
bryo, rather than requiring them to be localized around the vegetal
pole as suggested in a recent model (Croce and McClay, 2006),
although this would be inconsistent with the well established
observations that material transplanted into other locations from
Fig. 6. Distribution of gene expression for candidate dorsalizing factors in the 8-cell embryo. A. Expression of maternal Wnt11b shows substantial animal–vegetal asym-
metry, without any consistent dorsal–ventral segregation, and, speciﬁcally, little difference between dorsal and ventral blastomeres, in either the PolyAþ or total mRNA
prepared libraries. B. Expression of maternal Disheveled is relatively uniform throughout the early cleavage stage embryo, suggesting that these mRNAs were not con-
centrated at the vegetal pole of the oocyte or the fertilized egg.
E. De Domenico et al. / Developmental Biology 408 (2015) 252–268266around the vegetal pole has a dorsalizing effect (Fujisue et al.,
1993; Holowacz and Elinson, 1993; Kageura, 1997).4. Conclusions
Using a sensitive and stringent analysis we have found no
evidence for asymmetric distribution of maternal mRNAs along
either the dorsal–ventral or the left–right axes. We thus provide a
considerable weight of evidence in support of the original sug-
gestion (Flachsova et al., 2013) that the distribution of maternal
mRNAs in the fertilized egg, inherited from the oocyte, is essen-
tially undisturbed by cortical rotation.
We have shown that close to 7% of genes in the 8-cell stage
embryo, with sufﬁcient levels of expression to test for asymmetry,
show discernible differential expression between the animal and
vegetal poles, and that this enrichment is signiﬁcantly more
marked at the vegetal than the animal pole. Transcriptional ac-
tivity in the 8-cell embryo is not sufﬁcient to produce the observed
polar enrichment (Collart et al., 2014; Yang et al., 2002), so the
enrichment must arise from the initially asymmetric distribution
of maternal mRNAs in the egg, inherited from the oocyte.
We have conﬁrmed the lower enrichment at the animal pole
compared to the vegetal pole, with all but 2/460 animal polemRNAs enriched byo3-fold. This is signiﬁcantly lower than the 3–
10 folds previously reported (Grant et al., 2014; King et al., 2005),
although these ﬁgures may be inﬂuenced by differences in ex-
perimental design.
It has recently been pointed out that (unlike vegetal pole lo-
calization) “the subcellular mechanism [in the oocyte] by which
animal transcripts are localized has yet to be revealed” (Grant
et al., 2014). We might speculate that the smaller fold changes at
the animal pole (which are nevertheless consistent between em-
bryos) are a consequence of mRNAs gradients in the oocyte or egg,
set up as the internal structure of these large cells develops, rather
than evidence of speciﬁc, animal pole directed transport me-
chanisms, or later functional requirement, although the signiﬁcant
enrichment of human disease genes in the animal pole cohort
might suggest otherwise. There is clearly much still to be learned
about the distribution of maternal mRNAs in the maturing oocyte
and the early embryo.
A wide range of birth defects is known to be associated with
incorrect speciﬁcation of body plan asymmetry (Vandenberg et al.,
2013), and understanding the molecular determinants that es-
tablish the correct axial asymmetries during embryogenesis will
be critical. The results obtained here provide a new and more
complete insight into spatial distribution and identiﬁcation of
maternal mRNA in the early embryo. This knowledge may help to
E. De Domenico et al. / Developmental Biology 408 (2015) 252–268 267shed light on these defects or other genetic congenital disorders.Acknowledgments
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